EDITORIAL: Don’t abuse anti-HIV drug

Kenya is preparing to introduce Lenacapavir, a long-acting HIV prevention injection that will be available next month.

It is a form of pre-exposure prophylaxis (PrEP) that works to prevent HIV infection and, unlike daily oral PrEP pills, it is given twice a year, offering a practical alternative for people who struggle with daily medication.

There is a misperception in some communities that Lenacapavir is a vaccine or a licence to stop using condoms and other prevention methods. This is not correct and must be corrected in public dialogue.

Lenacapavir is not a vaccine; it does not provide sterilising immunity, and it does not protect against other sexually transmitted infections such as gonorrhea and pregnancy. It is an additional tool in the HIV prevention toolbox, not a replacement for condoms, regular testing or other safe-sex practices.

Even with highly effective prevention medicines, no single intervention eliminates risk. Individuals must still use combinations of prevention strategies that fit their circumstances and personal risk.

Health educators and clinicians should emphasise that even those using Lenacapavir need to practise safe sex, including the use of condoms, and seek regular sexual health services.

QUOTE OF THE DAY: “Half the trouble in life is caused by pretending there isn't any.” —American Pulitzer prize-winning novelist Edith Wharton was born on January 24, 1862